Sinai

Mount Sinai Researchers Use New Deep Learning Approach to Enable Analysis of Electrocardiograms as Language

Retrieved on: 
Tuesday, June 6, 2023
National Center for Voice and Speech, Data-driven, Learning, Heart, Icahn School of Medicine at Mount Sinai, Department of Medicine – University of Pamplona, ChatGPT, National Heart, Lung, and Blood Institute, Pathology, ECG, Intelligence, CNN Pipeline, Lung, Language, CNN, Science, Hospital, Genetic disorder, Patient, Physician, Machine learning, Hypertrophic cardiomyopathy, Division, Algorithm, DOI, Architecture, Diagnosis, Artificial intelligence, Automated ECG interpretation, Mount Sinai Health System, MPH, NIH, Sinai, D3M, Disease, Medical device, Medical imaging, MD, Medicine

NEW YORK, June 6, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the accuracy and effectiveness of ECG-related diagnoses, especially for cardiac conditions where limited data is available on which to train.

Key Points: 
  • Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
  • NEW YORK, June 6, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
  • Researchers are using a related image-generating model to create discrete representations of small parts of the ECG, enabling analysis of the ECG as language.
  • Researchers pretrained HeartBEiT on 8.5 million ECGs from 2.1 million patients collected over four decades from four hospitals within the Mount Sinai Health System.

Kissinger at 100: his legacy might be mixed but his importance has been enormous

Retrieved on: 
Saturday, May 27, 2023
Vietnam War, Nobel Peace Prize, Sinai, Interview, Harvard University, United States Department of State, Salt, Policy, Negotiation, Instinct, Davos, Government, Anglo-French Wars, Student, J'Accuse...!, Ethics, World, International order, International law, Management, Tourism, Drug, Arms industry, Diplomacy, USSR, American

From the late 1960s, Kissinger played a momentous role in shaping US foreign policy and navigating the complex dynamics of the cold war era.

Key Points: 
  • From the late 1960s, Kissinger played a momentous role in shaping US foreign policy and navigating the complex dynamics of the cold war era.
  • His contributions to international relations have had a lasting impact, earning him recognition as a visionary strategist and diplomat.
  • Few would disagree that Kissinger’s influence on US foreign policy has been immense, importantly as a thinker and academic.
  • Regardless, Kissinger never wavered in his conviction that his diplomacy should put US interests first while appreciating the complexity of the international scene.

Foreign policy

    • From his days in government, and then through his continuing influence as a renowned scholar, Kissinger’s strategic thinking and diplomatic approach have shaped US foreign policy in significant ways.
    • The biggest contribution Kissinger made to US foreign policy was his advocacy for “realpolitik”.
    • He believed that the US should base its foreign policy decisions on a clear and systematic assessment of power dynamics and the pursuit of geopolitical stability.

J'accuse: Kissinger’s critics

    • Among his most vocal and persistent critics was the late British writer and journalist Christopher Hitchens.
    • Hitchens’ book “The Trial of Henry Kissinger” presented a series of arguments about alleged war crimes committed by his American “nemesis”.
    • Hitchens accused Kissinger of disregarding international law and violating the sovereignty of many nations.
    • Despite all the criticism, Kissinger endured and remains a respected international relations scholars and advisor to this day.

Mount Sinai Researchers Awarded $12 Million NIH Grant to Create a Center to Unravel Novel Causes of Food Allergy & Atopic Dermatitis That Uses a Systems Biology Approach

Retrieved on: 
Thursday, January 26, 2023
University of North Carolina at Pembroke, University, Sunbeam, Atopic dermatitis, MPH, Johns Hopkins, Diagnosis, Bangladesh Technical Education Board, Skin, Infection, National Institute of Allergy and Infectious Diseases, Systems biology, Anaphylaxis, Periodic breathing, Master of Philosophy, Sinai, Risk, Dermatitis, Food allergy, Chapel Hill, Principal, Parent, National Jewish Health, Biology, Food, Allergy, Vaccine, MD, Northwestern

NEW YORK, Jan. 26, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.

Key Points: 
  • Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.
  • The Systems Biology of Early Atopy (SunBEAm) Analysis and Bioinformatics Center intends to develop a better understanding of allergy development.
  • NEW YORK, Jan. 26, 2023 /PRNewswire-PRWeb/ -- Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.
  • The Systems Biology of Early Atopy (SunBEAm) Analysis and Bioinformatics Center intends to develop a better understanding of allergy development.

Mount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma Patients

Retrieved on: 
Thursday, September 1, 2022
Icahn School of Medicine at Mount Sinai, National Cancer Institute, Artificial intelligence, News, Mount Sinai Hospital, Informatics, U.S. News & World Report Best Hospitals Rankings, U.S. News & World Report, NEW, Urology, Twitter, Rehabilitation, Patient, Survival, Antigen, Nursing, Hospital, Mount Sinai Hospital (Manhattan), Newsweek, World, Translational research, Health system, CAR, Community, Multiple myeloma, Journal of Neurology, Neurosurgery, and Psychiatry, MD, School, NCI, Mount Sinai Kravis Children's Hospital, Health, YouTube, Monoclonal antibody, Physician, Salvage therapy, No, National, National Institutes of Health, Genomics, Sinai, Mount Sinai Health System, Knowledge, Clinical trial, Vaccine, Pharmaceutical industry, Medicine, Facebook, Geriatrics, Medicine, Ophthalmology, Orthopedic surgery

NEW YORK, Sept. 1, 2022 /PRNewswire-PRWeb/ -- Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time—they are meant to enhance the immune system's destruction of tumor cells.

Key Points: 
  • Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.
  • NEW YORK, Sept. 1, 2022 /PRNewswire-PRWeb/ -- Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.
  • In the August 26 online edition of Blood Advances , Mount Sinai researchers report that sequential use of different T-cell redirection therapies in these multiple myeloma patients is possible and could lead to good patient outcomes and survival.
  • In a retrospective analysis, researchers identified 58 multiple myeloma patients who participated in a bispecific antibodies clinical trial at Mount Sinai and underwent salvage therapy due to relapse.

The Mount Sinai Hospital's Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year

Retrieved on: 
Tuesday, July 27, 2021
Continuum Health Partners, Hospitals, Manhattan, Health care, Mount Sinai Hospital, Mount Sinai West, Sinai-Grace Hospital, Mount Sinai Morningside, Mount Sinai Beth Israel, Mount Sinai South Nassau, Sinai Hospital, Sinai

In this year's report, The Mount Sinai Hospital saw improvements in six specialties, including significant leaps in Cancer, which rose to No.

Key Points: 
  • In this year's report, The Mount Sinai Hospital saw improvements in six specialties, including significant leaps in Cancer, which rose to No.
  • The Mount Sinai Hospital specialties ranked among the top 50 nationally this year were Geriatrics, ranked No.
  • Mount Sinai Beth Israel, Mount Sinai Morningside, Mount Sinai West, and Mount Sinai South Nassau were all ranked regionally.
  • 14 in the nation for National Institutes of Health funding, Newsweek's "The World's Best Smart Hospitals" ranks The Mount Sinai Hospital as No.

Mount Sinai South Nassau Selects AcuityPlus from Harris OnPoint to Deliver High Quality Patient-Centered Care

Retrieved on: 
Tuesday, May 25, 2021
Healthcare in New York City, Mount Sinai Health System, Mount Sinai South Nassau, Health care, Sinai, American Nurses Credentialing Center, Health

NIAGARA FALLS, N.Y., May 25, 2021 /PRNewswire/ -- The Harris OnPoint business unit of Harris Computer welcomes Mount Sinai South Nassau as a new AcuityPlus partner.

Key Points: 
  • NIAGARA FALLS, N.Y., May 25, 2021 /PRNewswire/ -- The Harris OnPoint business unit of Harris Computer welcomes Mount Sinai South Nassau as a new AcuityPlus partner.
  • Through this partnership, Mount Sinai South Nassau looks to AcuityPlus to provide it's evidence-based methodologies, which have been mapped and integrated into their system, to ensure the quantity of care (acuity) and type of care (complexity) are tailored to the needs of each patient.
  • The Long Island flagship hospital of the Mount Sinai Health System, Mount Sinai South Nassau is designated as a Magnet hospital by the American Nurses Credentialing Center (ANCC) for outstanding nursing care.
  • Mount Sinai South Nassau is one of the region's largest hospitals, with 455 beds, more than 900 physicians and 3,500 employees.

North American Partners in Anesthesia announces new partnership with Sinai Chicago, expanding NAPA's anesthesia management services to more Chicagoland hospitals

Retrieved on: 
Tuesday, May 18, 2021
Hospitals, Health care, Health, Trauma centers, East Harlem, Fifth Avenue, Mount Sinai Hospital, Upper East Side, Sinai-Grace Hospital, Holy Cross Hospital, Sinai, Anesthesia

b'MELVILLE, N.Y., May 18, 2021 /PRNewswire/ -- North American Partners in Anesthesia (NAPA) is growing its geographic footprint in the Chicagoland area, recently launching with a new partnership with Sinai Chicago on May 6th.

Key Points: 
  • b'MELVILLE, N.Y., May 18, 2021 /PRNewswire/ -- North American Partners in Anesthesia (NAPA) is growing its geographic footprint in the Chicagoland area, recently launching with a new partnership with Sinai Chicago on May 6th.
  • Under this new relationship, NAPA will provide anesthesia services across all Sinai Chicago sites, including Mount Sinai Hospital and Holy Cross Hospital in Chicago, Illinois.
  • Mount Sinai Hospital is a Level I trauma center located in the Douglass Park neighborhood on Chicago\'s West side.
  • "\nAs a clinician-led organization, North American Partners in Anesthesia (NAPA) is redefining healthcare, delivering unsurpassed excellence to its partners and patients every day.

Mount Sinai South Nassau Kicks Off Interoperability Transformation with Infor Healthcare

Retrieved on: 
Monday, September 21, 2020
Geography of Asia, Western Asia, Moses, Sacred mountains, Sinai Peninsula, Bible, Fast Healthcare Interoperability Resources, JSON, Mount Sinai South Nassau, Sinai, Interoperability

NEW YORK, Sept. 21, 2020 /PRNewswire/ --Infortoday announced that Mount Sinai South Nassau (MSSN) has selected Infor Cloud Cloverleaf to increase interoperability across its network of healthcare services and providers.

Key Points: 
  • NEW YORK, Sept. 21, 2020 /PRNewswire/ --Infortoday announced that Mount Sinai South Nassau (MSSN) has selected Infor Cloud Cloverleaf to increase interoperability across its network of healthcare services and providers.
  • Infor continues to be the right partner because they have proven to our organization that Cloverleaf scales to handle our current needs and we have a clear path towards interoperability via APIs and FHIR," said Matt Runyan, Mount Sinai South Nassau chief information officer.
  • "Now, teams at Mount Sinai South Nassau will be able to better collaborate within and across departments, enhancing the quality, safety and efficiency of the patient care we provide.
  • It will give us more efficient tools to be more proactive," said Dr. Ashok Kumar, chief medical information officer consultant at Mount Sinai South Nassau.

Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding

Retrieved on: 
Wednesday, July 8, 2020
Food and Drug Administration, United States Public Health Service, Sinai, Hyperimmune, Health, Articles, Food and Drug Administration, United States Public Health Service, Sinai, Hyperimmune, Health, Articles

The collaborators will establish plasma collection capabilities at Mount Sinai through an extension of ImmunoTeks FDA-approved establishment license and the transfer of technical know-how to Mount Sinai.

Key Points: 
  • The collaborators will establish plasma collection capabilities at Mount Sinai through an extension of ImmunoTeks FDA-approved establishment license and the transfer of technical know-how to Mount Sinai.
  • The front-line health care workers and others who protect us are a top priority for reducing the impact of COVID-19.
  • Emergent is drawing from decades of experience with our human hyperimmune platform, on which several products have been FDA-licensed, to develop COVID-HIG.
  • This unprecedented public health crisis is a critical moment for Americans to donate plasma, said Jerome Parnell III, CEO and President, ImmunoTek Bio Centers.

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test

Retrieved on: 
Tuesday, May 19, 2020
Health, Philosophy of technology, Techne, Mount Sinai Health System, Sinai, Kantaro, Food and Drug Administration, Articles

Kantaro has partnered with Bio-Techne to develop a test kit based on the Mount Sinai test and to scale up, manufacture, sell and distribute these kits.

Key Points: 
  • Kantaro has partnered with Bio-Techne to develop a test kit based on the Mount Sinai test and to scale up, manufacture, sell and distribute these kits.
  • Based on this success, Bio-Techne and Mount Sinai have partnered to develop high-quality production test kits, based upon the Mount Sinai test, which can be manufactured and distributed globally at scale.
  • Kantaro will lead regulatory processes with the intention of submitting the scaled assay for FDA EUA review in May.
  • Kantaro Biosciences ("Kantaro"), a Mount Sinai Health System venture, is dedicated to ensuring that diagnostic tests for critical health challenges are accessible to all.